Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
September 10, 2025Therapeutic Advances in Drug SafetyOpen Access

Artificial intelligence in pharmacovigilance: advancing drug safety monitoring and regulatory integration

View Full Paper
Ask AI
Bookmark
Share

Authors

ANAnkit NagarJGJogarao GobburuACAloka Chakravarty

Discussion

Loading...

Member takes

Overview

This review highlights AI's potential to improve drug safety monitoring, emphasizing implementation challenges and regulatory integration.

Key Points

  • AI enhances drug safety monitoring capabilities, ensuring better risk management and faster response times.
  • The review identifies practical implementation challenges including interpretability and bias in AI systems.
  • It examines AI's ability to provide actionable insights, potentially transforming how pharmacovigilance is conducted.
  • The transition from experimental to routine AI use in pharmacovigilance is essential for future drug safety improvements.

Cite This Study

Nagar et al. (2025) studied this question.

synapsesocial.com/papers/68c23ed7b210217d64793acfhttps://doi.org/10.1177/20420986251361435
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Artificial intelligence in pharmacovigilance signal management: a review of tools, implementations, research, and regulatory landscape.2025
  2. 2Artificial intelligence in pharmacovigilance: a narrative review and practical experience with an expert-defined Bayesian network tool2025
  3. 3Optimizing Drug Safety and Compliance in Real-Time by Using Block chain and Artificial Intelligence for Integrated Clinical Data Management and Pharmacovigilance2025
  4. 4Rethinking drug safety signal detection and causality assessment in the age of AI: the risks of incomplete data and biased insights2025 · 8 citations
  5. 5Enhancing the Patient Safety by using the Explainable Artificial Intelligence in Pharmacovigilance2025